Meet The Team
Meet The Team
Allurion is a global company with a global vision. We have assembled the brightest minds across industries and the world to pioneer our mission to end obesity.
Shantanu Gaur co-founded Allurion Technologies with Samuel Levy in 2009. Shantanu completed his A.B. in Biology from Harvard College, where he graduated summa cum laude with election to Phi Beta Kappa. Shantanu received his M.D. from Harvard Medical School.
Samuel Levy co-founded Allurion Technologies with Shantanu Gaur in 2009. Samuel graduated summa cum laude with a B.S. in Molecular Biophysics and Biochemistry from Yale College and with an M.D. from Harvard Medical School. He was a Fulbright Scholar to France and served pharmaceutical and medical clients as a consultant at McKinsey & Company.
As Cynosure’s Chairman, President and Chief Executive Officer from 2003 to 2017, Michael Davin oversaw sales growth from $20 million to $430 million, including significant international expansion, led the company’s initial public offering and listing on the NASDAQ, and executed key acquisitions. Under his leadership, Cynosure achieved compound annual revenue growth of more than 20 percent and became one of the largest and most profitable companies in the aesthetic industry. Cynosure was sold to Hologic for $1.65 billion in March 2017.
Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry and is currently Dermavant’s Chief Executive Officer. Prior to joining Dermavant, Mr. Zavodnick served as Chief Commercial Officer and President of Aesthetics and Therapeutics at Revance. He previously served in global leadership roles at ZELTIQ Aesthetics, prior to the company’s acquisition by Allergan, at Galderma Laboratories where he was President and General Manager of North America, and at Alcon Laboratories. He is a member of the board of directors of the Children’s Skin Disease Foundation.
Krishna Gupta is the Founder and Managing Partner of Remus Capital. A venture capital firm that focuses on building, not betting on, science- and technology-enabled companies. Mr. Gupta has been involved with Allurion since 2010, and Remus led Allurion’s $27M Series C funding. Under Mr. Gupta’s leadership, Remus has built a powerful portfolio of innovative companies and a global investor base from more than 20 countries. Mr. Gupta has extensive experience helping high-growth companies scale to become category leaders.
Dr. John Morton is the System Lead for Surgical Quality and Bariatric Services in the Yale New Haven Health System of 6 hospitals and Vice-Chair for Quality, Division Chief for Bariatric and Minimally Invasive Surgery and Professor in the Department of Surgery at the Yale School of Medicine. He served as Chief of Bariatric and Minimally Invasive Surgery, Clinic Chief for the Bariatric and Metabolic Inter-Disciplinary Clinic and Director of Bariatric and Minimally Invasive Surgery Fellowship at Stanford University School of Medicine from 2003-2019
Dr. Bruce Schirmer has been on faculty at the University of Virginia since 1985 and serves as the Stephen H. Watts Professor of Surgery, the vice chair of the Department of Surgery, the division chief of general surgery and director of the surgery nutrition support service. Previously, he was the program director of surgery for 17 years.
Dr. Harold S Solomon specializes in internal medicine in Chestnut Hill, MA and has over 57 years of experience in the field of medicine. He graduated from Medical College of Georgia with his medical degree in 1965. He is affiliated with numerous hospitals in Massachusetts and more, including Beth Israel Deaconess Medical Center.
Dr. Peter W. Siersma is an internist in Williamsburg, Massachusetts and is affiliated with Cooley Dickinson Hospital. He received his medical degree from UMass Chan Medical School and has been in practice for more than 20 years.
Dr. Richard I. Rothstein is the Joseph M. Huber Professor of Medicine and Chair of the Department of Medicine at the Geisel School of Medicine at Dartmouth. He is also a Professor of Surgery. Dr. Rothstein was Director of Gastroenterology Research and Director of the Gastrointestinal Motility Lab, before becoming the Section Chief of Gastroenterology and Hepatology in 1997, a position he held for 15 years. He served as the Associate Dean for Continuing Medical Education from 1993 to 2013.
Dr. Jordan Busch is a founder and partner of Personal Physicians HealthCare. He is a Diplomate of the American Board of Internal Medicine. He has appointments to the medical staff at the Beth Israel Deaconess Hospital, the Brigham and Woman’s Hospital, New England Baptist Hospital, and Newton Wellesley Hospital, and a faculty appointment to Harvard Medical School as a Clinical Instructor in Medicine.
Prof. Dr. E.M.H. Mathus-Vliegen is a Gastroenterologist and Professor in Clinical Nutrition in the Department of Gastroenterology and Hepatology at the Academic Medical Center University of Amsterdam.
Dr. Nezam H. Afdhal is the Chief of the Division of Gastroenterology, Hepatology and Nutrition at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. Dr. Afdhal received his MD degree in 1981 from the Royal College of Surgeons in Ireland and did fellowship training at University College Dublin and at Boston University School of Medicine.
Dr. Daniel B. Jones is Professor of Surgery at Harvard Medical School and Vice Chair of Surgery at the Beth Israel Deaconess Medical Center in Boston. He graduated from Cornell University and Weil Cornell Medical School. He completed residency at Washington University-Barnes Hospital where he did a fellowship at the Washington University Institute for Minimally Invasive Surgery.
Dr. Jaime Ponce is the medical director of CHI Memorial's Weight Management Center. He also served as the medical director of the bariatric surgery program at Hamilton Medical Center in Dalton, Georgia. Dr. Ponce received his medical degree from I.T.E.S.M. School of Medicine in Monterrey, Mexico. He completed his general surgery residency at East Tennessee State University.